Kenneth W. Tuell, RPh, BCGP
Articles by Kenneth W. Tuell, RPh, BCGP
Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis
ByAndrew J. Klink, PhD, MPH,Tammy G. Curtice, PharmD, MBA, MS,Kiran Gupta, PhD, MPharm,Kenneth W. Tuell, RPh, BCGP,A. Richard Szymialis, RPh,Damion Nero, PhD,Bruce A. Feinberg, DO This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.
Understanding Total Cost of Care in Advanced Non-Small Cell Lung Cancer Pre- and Postapproval of Immuno-Oncology Therapies
ByBeata Korytowsky, MA,Janna Radtchenko, MBA,Esmond D. Nwokeji, PhD,Kenneth W. Tuell, RPh, BCGP,Jonathan K. Kish, PhD, MPH,Bruce A. Feinberg, DO